IL-12 further causes a substantial amount of IFNγ to be produced (a cytostatic/cytotoxic and anti-angiogenic agent), in addition, IL-12 can upregulate MHC I and II expression on tumor cells for improved antigen recognition and lysis. The gene discussed is IFNG; the disease is neoplasm.